Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data

Kyong Ju Lee, Yuan Ji

Phase I oncology trials aim to identify a safe dose - often the maximum tolerated dose (MTD) - for subsequent studies. Conventional designs focus on population-level toxicity model…